安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Nivolumab - Wikipedia
Nivolumab, sold under the brand name Opdivo, is an anti-cancer medication in the class of immune checkpoint inhibitors It selectively binds and blocks the programmed death-1 (PD-1) receptor on T cells, thereby facilitating their activation It is used to treat a number of types of cancer [2]
- Nivolumab: Uses, Dosage, Side Effects Warnings - Drugs. com
Nivolumab is an immune checkpoint inhibitor that works by interfering with the growth and spread of cancer cells Cancer cells express PD-L1 proteins that bind to T-cell PD-1 receptors, creating an immune "off switch " Nivolumab blocks PD-1 receptors, preventing this binding and removing the brake on T cells to attack cancer
- 纳武利尤单抗 - 维基百科，自由的百科全书
纳武利尤单抗（Nivolumab，商品名Opdivo，中文商品名欧狄沃，小野制药特许版本商品名保疾伏）是一种用于治疗癌症的完全人源化抗PD-1单克隆抗体。
- Nivolumab - NCI - National Cancer Institute
Nivolumab works by binding to and blocking the protein PD-1 on the surface of some cancer cells, which keeps cancer cells from suppressing the immune system This allows the immune system to attack the cancer cells Nivolumab is a type of immunotherapy drug called an immune checkpoint inhibitor
- OPDIVO® (nivolumab)
OPDIVO® (nivolumab) is a prescription medication that treats certain types of cancer Read the indications, side effects, and more Please see Indication and Important Safety Information
- Nivolumab (intravenous route) - Mayo Clinic
Nivolumab is a monoclonal antibody that affects the immune system and helps control the growth of cancer cells This medicine is to be given only by or under the supervision of your doctor This product is available in the following dosage forms:
- Nivolumab (Opdivo®) - Macmillan Cancer Support
Nivolumab (Opdivo ®) is an immunotherapy drug It may also be called a checkpoint inhibitor Nivolumab is used to treat melanoma, non-small cell lung cancer, kidney cancer, Hodgkin lymphoma, mesothelioma, bladder cancer, oesophageal (gullet) or stomach cancer, and some colorectal or head and neck cancers
- Nivolumab: Cancer Treatment Uses, Side Effects, Warnings - MedicineNet
Nivolumab is a type of targeted therapy that does not directly kill cancer cells, but targets and alters a specific cell mechanism that promotes cancer growth and spread Nivolumab works by stimulating the body’s own immune system to fight against cancer cells
|
|
|